MedTrace Logo

L-Citrulline in Patients With Post-Polio Syndrome

NCT02801071 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-01-23

No results posted yet for this study

Summary

The purpose of the study is to show that the intake of L-citrulline improves muscle function in patients with Post-Polio Syndrome (PPS).

Conditions

  • Post-Polio Syndrome

Interventions

DRUG

15g L-citrulline daily p.o.

DRUG

Placebo

Sponsors & Collaborators

  • Dirk Fischer

    lead OTHER

Principal Investigators

  • Dirk Fischer, Prof. · University Children's Hospital Basel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-14
Primary Completion
2017-08-15
Completion
2018-10-05

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02801071 on ClinicalTrials.gov